NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Jefferies Financial Group Inc. (“Jefferies” or the “Company”) (NYSE: JEF). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jefferies Financial Group Inc. - JEF

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc (“Waldencast” or the “Company”) (NASDAQ: WALD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Venu Holding Corporation (“Venu” or the “Company”) (NYSE: VENU). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Venu Holding Corporation - VENU

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Caledonia Mining Corporation Plc (“Caledonia Mining” or the “Company”) (NYSE: CMCL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caledonia Mining Corporation Plc - CMCL

EL's North America Trends Improve but Asia Remains the Wild Card — Neutral

EL   Zacks Investment Research — January 06, 2026

Estee Lauder shows signs of North America stabilization as declines ease, but uneven Asia demand and volatile travel retail keep the regional balance in question.

image for news EL's North America Trends Improve but Asia Remains the Wild Card

Celestica Stock Rises 21.6% in Three Months: Should You Invest? — Positive

CLS   Zacks Investment Research — January 06, 2026

CLS shares are up 21.6% in three months as AI data center demand boosts networking sales, but premium valuation and customer concentration risks remain.

image for news Celestica Stock Rises 21.6% in Three Months: Should You Invest?

Citigroup Stock Reaches New 52-Week High: Hold or Fold Now? — Positive

C   Zacks Investment Research — January 06, 2026

C hits a new 52-week high as strategic exits, easing regulation and a softer-rate backdrop lift confidence, but is there more upside left? Let us find out.

image for news Citigroup Stock Reaches New 52-Week High: Hold or Fold Now?

Can S&P 500 Sustain Double-Digit Winning Streak in 2026? ETFs in Focus — Neutral

GLD  SMH  XLK   Zacks Investment Research — January 06, 2026

Can the S&P 500 extend its double-digit run in 2026? Valuations, Fed shifts, AI risks loom as ETFs like SPY, XLK, GLD take focus.

image for news Can S&P 500 Sustain Double-Digit Winning Streak in 2026? ETFs in Focus

2 Auto Retailers Poised to Outperform in a Shifting 2026 Landscape — Positive

ABG  AN   Zacks Investment Research — January 06, 2026

With the Zacks Auto Retail industry ranked favorably, stocks like AN and ABG are worth investing in.

image for news 2 Auto Retailers Poised to Outperform in a Shifting 2026 Landscape

Can ETF Winners of Q4 of 2025 Rally in Q1 of 2026? — Positive

BBC  ILIT  LITP  SBIO  SIVR  SLV   Zacks Investment Research — January 06, 2026

Wall Street put up a modest show in the final quarter of 2025, with the S&P 500 advancing only 1.9%, the Dow Jones gaining 3.3% and the Nasdaq Composite adding about 2.1%. The small-cap index Russell 2000 added 1.6% during that period.

image for news Can ETF Winners of Q4 of 2025 Rally in Q1 of 2026?

SAN FRANCISCO, Jan. 6, 2026 /PRNewswire/ -- Investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) saw the price of their shares crater 50% on December 31, 2025 after the company announced its receipt of a complete response letter ("CRL") from the FDA for its proposed treatment of patients with hypercortisolism (also known as Cushing's syndrome) – relacorilant. The news and severe market reaction has prompted national shareholder rights law firm Hagens Berman to commence an investigation into whether Corcept may have misled investors about relacorilant's efficacy and commercial prospects.

image for news Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman

Hormel: Buy This Dividend Aristocrat While It Dips — Positive

HRL   Seeking Alpha — January 06, 2026

Hormel Foods trades near 52-week lows with a forward P/E of 15.7 and an attractive 5.1% dividend yield. HRL demonstrates resilient organic growth across all segments, supported by strong brands and ongoing portfolio modernization. Management guides for 1%–4% organic sales growth and 7% operating income growth midpoint in fiscal 2026 as margin pressures ease.

image for news Hormel: Buy This Dividend Aristocrat While It Dips

NEW YORK CITY, NEW YORK / ACCESS Newswire / January 6, 2026 / Allison Worldwide and Stagwell (NASDAQ: STGW ) are turbocharging their global communications capabilities and positioning for growth in healthcare with the appointment of industry veteran Wendy Lund as Global Chief Executive Officer, Allison Worldwide and Stagwell's new Vice Chair of Health. Joining Jan. 12, Lund brings more than three decades of expertise and visionary leadership to the dual role.

image for news Allison Worldwide and Stagwell (STGW) Bolster Communications and Healthcare Capabilities in Naming Wendy Lund as Global CEO, Allison and Stagwell's Vice Chair of Health

NXP Advances Edge AI Leadership with New eIQ Agentic AI Framework — Neutral

NXPI   GlobeNewsWire — January 06, 2026

NXP announced its new eIQ Agentic AI Framework, a trusted foundation to rapidly prototype and deploy optimized, secure, autonomous AI systems at the edge.

image for news NXP Advances Edge AI Leadership with New eIQ Agentic AI Framework

NEW YORK--(BUSINESS WIRE)--Today NBCUniversal, independent agency RPA, FreeWheel, and Newton Research announced a partnership to introduce a breakthrough approach to buying premium video using agentic AI across both linear and digital. In a first-of-its-kind proof-of-concept, an agency can execute and optimize a single premium video investment across platforms in seconds, as illustrated in the video demo here. Newton, NBCUniversal, and FreeWheel's agents orchestrate cross-platform video buying.

image for news NBCUniversal, RPA, FreeWheel, and Newton Research Introduce Agentic AI Buying Across Linear and Digital for Premium Video

IMDb Announces the Most Anticipated Movies and Series of 2026 — Neutral

AMZN   Business Wire — January 06, 2026

SEATTLE--(BUSINESS WIRE)--IMDb (www.imdb.com), the world's most popular and authoritative source for information on movies, TV shows, and celebrities, today unveiled the most anticipated movies and new series of 2026. Rather than base its annual rankings on small statistical samplings, IMDb determines its list of the most anticipated titles by the actual page views of the more than 250 million monthly visitors to IMDb. This exclusive and definitive data is derived from the IMDbPro MOVIEmeter ra.

image for news IMDb Announces the Most Anticipated Movies and Series of 2026

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Primo Brands Corporation (“Primo” or “the Company”) (NYSE: PRMB; PRMW) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired (i) the publicly traded common stock of Primo Water Corporation (“Primo Water”) between June 17, 2024 through November 8, 2024, inclusive, and/or (ii) the publicly traded common …

image for news PRMB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Primo Brands Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against agilon health, inc. (NYSE: AGL) and certain of its officers.

image for news Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Klarna Group plc (NYSE: KLAR) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Klarna securities pursuant to the registration statement and prospectus issued in connection with the Company's September 10, 2025 initial public offering ("IPO").

image for news Bronstein, Gewirtz & Grossman LLC Urges Klarna Group plc Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Stride securities between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”).

image for news Bronstein, Gewirtz & Grossman LLC Urges Stride, Inc. Investors to Act: Class Action Filed Alleging Investor Harm